ElendiLabs Logo

Questions? 10 seconds to sign up

Join the platform

Back to Articles

Need Regulatory Help? Try Our Platform

Post your regulatory questions or request quotations from verified pharmaceutical consultants worldwide. Get matched with experts who specialize in your market.

Other

February 11, 2026

Approximately 5 minutes

Icelandic Regulation on Reprocessing of Single-Use Medical Devices No. 1154/2021

Icelandic Regulation on Reprocessing of Single-Use Medical Devices No. 1154/2021

1. Purpose

The regulation stipulates the reprocessing of single-use medical devices to ensure safety and functionality equivalent to the original device, emphasizing processes such as cleaning, disinfection, and testing.

2. Scope

The regulation applies to the reprocessing of single-use medical devices, including within healthcare institutions and by external reprocessors.

3. Definitions

  • Single-use device: Device intended for use on one patient during one procedure (cf. item 8 of paragraph 1 of Article 4 of Act No. 132/2020).
  • Reprocessing: Process for reuse of a device safely, including cleaning, disinfection, sterilization, testing, and restoration of safety (cf. item 9 of paragraph 1 of Article 4 of Act No. 132/2020).
  • Reprocessor: Healthcare institution or external entity reprocessing single-use devices (cf. item 1 of Article 2 of Implementing Regulation (EU) 2020/1207).
  • Reprocessing cycle: Cycle of all reprocessing phases to ensure safety and functionality (cf. item 2 of Article 2 of Implementing Regulation (EU) 2020/1207).
  • Manufacturer's specification: Instructions for maintenance and repairs in the device manual (cf. item 11 of paragraph 1 of Article 4 of Act No. 132/2020).
  • External reprocessor: Entity reprocessing devices at the request of a healthcare institution (cf. item 3 of Article 2 of Implementing Regulation (EU) 2020/1207). https://island.is/reglugerdir/nr/1154-2021

4. Obligations

Reprocessing must comply with common specifications in Implementing Regulation (EU) 2020/1207. Reprocessing ensures equivalent safety and functionality. Reprocessing falls under manufacturer obligations according to Regulation (EU) 2017/745, with exemptions from Implementing Regulation (EU) 2020/1207. https://island.is/reglugerdir/nr/1154-2021

5. Conformity Assessment

Reprocessing and reuse must follow common specifications in Implementing Regulation (EU) 2020/1207 to ensure safety and functionality. https://island.is/reglugerdir/nr/1154-2021

6. Registration

No specific provisions on registration in the regulation. https://island.is/reglugerdir/nr/1154-2021

7. Clinical Investigations

No specific provisions on clinical investigations in the regulation. https://island.is/reglugerdir/nr/1154-2021

8. Vigilance

The reprocessing cycle must ensure equivalent safety and functionality, with testing on technical and usage safety. https://island.is/reglugerdir/nr/1154-2021

9. Market Surveillance

The Icelandic Medicines Agency acts as the competent authority according to Implementing Regulation (EU) 2020/1207. Surveillance and penalties proceed according to Chapter VII of Act No. 132/2020 on medical devices. https://island.is/reglugerdir/nr/1154-2021

10. Language Requirements

No specific provisions on language requirements in the regulation. https://island.is/reglugerdir/nr/1154-2021

11. Penalties

Violations against the regulation are subject to surveillance and penalties in Act No. 132/2020, Chapter VII. https://island.is/reglugerdir/nr/1154-2021

Ask Anything

We'll follow up with you personally.

100% response rate • Reply within 7 business days

Your email will not be published. We'll only use it to notify you when we respond.

Need Expert Guidance?

Contact us at contact@elendilabs.com / +852 4416 5550